282 related articles for article (PubMed ID: 37372675)
21. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences].
Drozyńska E; Połczyńska K; Popadiuk S; Niedzwiecki M; Wiśniewski J; Balcerska A; Izycka-Swieszewska E; Bilska K; Balwierz W; Chełmecka L; Chybicka A; Dudeńko I; Karolczyk G; Kowalczyk J; Krawczuk-Rybak M; Kurylak A; Leszczyńska E; Matysiak M; Młynarski W; Pobudejska A; Sobol G; Sońta-Jakimczyk D; Szajdak K; Tredowska-Skoczeń D; Szmyd K; Trelińska J; Urasiński T; Wachowiak J; Wieczorek M; Wiśniewska-Slusarz H; Woźniak S; Woźniak W; Wysocki M
Med Wieku Rozwoj; 2011; 15(1):16-24. PubMed ID: 21786508
[TBL] [Abstract][Full Text] [Related]
22. Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements.
Poulos C; Cheng L; Zhang S; Gersell DJ; Ulbright TM
Mod Pathol; 2006 Jun; 19(6):766-71. PubMed ID: 16547466
[TBL] [Abstract][Full Text] [Related]
23. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
24. Germ Cell Tumors of the Ovary: A Review.
Ramalingam P
Semin Diagn Pathol; 2023 Jan; 40(1):22-36. PubMed ID: 36088223
[TBL] [Abstract][Full Text] [Related]
25. Malignant Mixed Germ Cell Tumors of the Ovary: An Analysis of 100 Cases Emphasizing the Frequency and Interrelationships of Their Tumor Types.
Safdar NS; Stall JN; Young RH
Am J Surg Pathol; 2021 Jun; 45(6):727-741. PubMed ID: 33284192
[TBL] [Abstract][Full Text] [Related]
26. Current controversies in the management of germ cell ovarian tumours.
Vazquez I; Rustin GJ
Curr Opin Oncol; 2013 Sep; 25(5):539-45. PubMed ID: 23942298
[TBL] [Abstract][Full Text] [Related]
27. [Germinal cell tumors in young and adolescent girls].
Rzepka-Górska I; Błogowska A; Zajaczek S; Zielińska D
Ginekol Pol; 2003 Sep; 74(9):840-6. PubMed ID: 14674134
[TBL] [Abstract][Full Text] [Related]
28. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
[TBL] [Abstract][Full Text] [Related]
29. Malignant mixed ovarian germ cell tumor with embryonal component.
Moniaga NC; Randall LM
J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):e1-3. PubMed ID: 20869284
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological study of malignant ovarian germ cell tumor].
Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
[TBL] [Abstract][Full Text] [Related]
31. [Mixed malignant germ cell tumor of ovary].
Sviracević B; Sedlar S; Malobabić D; Cuk D
Med Pregl; 2011; 64(1-2):93-5. PubMed ID: 21548277
[TBL] [Abstract][Full Text] [Related]
32. New and unusual aspects of ovarian germ cell tumors.
Young RH
Am J Surg Pathol; 1993 Dec; 17(12):1210-24. PubMed ID: 7694512
[TBL] [Abstract][Full Text] [Related]
33. Ovarian germ cell tumours: a 17-year study in a single unit.
Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
[TBL] [Abstract][Full Text] [Related]
34. RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours.
Xue D; Peng Y; Wang F; Allan RW; Cao D
Histopathology; 2011 Sep; 59(3):452-9. PubMed ID: 22034885
[TBL] [Abstract][Full Text] [Related]
35. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
[TBL] [Abstract][Full Text] [Related]
36. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
[TBL] [Abstract][Full Text] [Related]
37. Metastatic germ cell tumour in effusion cytology.
Saini T; Kundu R; Rastogi P; Rohilla M; Gupta P; Gupta N; Srinivasan R; Dey P
Cytopathology; 2022 Jul; 33(4):493-498. PubMed ID: 35347771
[TBL] [Abstract][Full Text] [Related]
38. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
39. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of OCT4 in primary central nervous system germ cell tumours.
Ngan KW; Jung SM; Lee LY; Chuang WY; Yeh CJ; Hsieh YY
J Clin Neurosci; 2008 Feb; 15(2):149-52. PubMed ID: 17997317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
